Concepedia

Orsolya Cseh

OC

Statistics

Publications

5

Citations

173

H-Index

5

Active since

2017

Affiliations

University of Calgary(Current)

Orsolya Cseh is an author at University of Calgary specializing in tumor biology, neuro-oncology, and medicine.

Top concepts

Publications per year

2017–2023

5

Publications

5

The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model

Katharine V. Jensen, Orsolya Cseh, Samuel Weiss et al. · PLoS ONE · 2017 · 68 citations · Full text

Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway

Ian J. Restall, Orsolya Cseh, Laura M. Richards et al. · Cancer Research · 2020 · 31 citations · Full text

, , +20

BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models

Xiaoguang Hao, Ravinder Kaur Bahia, Orsolya Cseh et al. · Neuro-Oncology · 2022 · 31 citations · Full text

Epigenetic and molecular coordination between HDAC2 and SMAD3-SKI regulates essential brain tumour stem cell characteristics

Ravinder Kaur Bahia, Xiaoguang Hao, Rozina Hassam et al. · Nature Communications · 2023 · 22 citations · Full text

SLUG Directs the Precursor State of Human Brain Tumor Stem Cells

Charles Chesnelong, Xiaoguang Hao, Orsolya Cseh et al. · Cancers · 2019 · 21 citations · Full text

, , +15

Rows per page

1–5 of 5